GRCh38/hg38 6q23.2(chr6:132455272-133141153)x3 AND See cases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 12, 2011
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000053388.4

Allele description [Variation Report for GRCh38/hg38 6q23.2(chr6:132455272-133141153)x3]

GRCh38/hg38 6q23.2(chr6:132455272-133141153)x3

Genes:

LOC129997172:ATAC-STARR-seq lymphoblastoid active region 25070 [Gene]
LOC129997173:ATAC-STARR-seq lymphoblastoid active region 25071 [Gene]
LOC129997174:ATAC-STARR-seq lymphoblastoid active region 25072 [Gene]
LOC129997177:ATAC-STARR-seq lymphoblastoid active region 25073 [Gene]
LOC129997178:ATAC-STARR-seq lymphoblastoid active region 25074 [Gene]
LOC129997179:ATAC-STARR-seq lymphoblastoid active region 25075 [Gene]
LOC129997181:ATAC-STARR-seq lymphoblastoid active region 25076 [Gene]
LOC129997182:ATAC-STARR-seq lymphoblastoid active region 25078 [Gene]
LOC129997183:ATAC-STARR-seq lymphoblastoid active region 25079 [Gene]
LOC129997184:ATAC-STARR-seq lymphoblastoid active region 25080 [Gene]
LOC129997175:ATAC-STARR-seq lymphoblastoid silent region 17551 [Gene]
LOC129997176:ATAC-STARR-seq lymphoblastoid silent region 17552 [Gene]
LOC129997180:ATAC-STARR-seq lymphoblastoid silent region 17553 [Gene]
LOC126859795:BRD4-independent group 4 enhancer GRCh37_chr6:133308297-133309496 [Gene]
LOC126859793:MED14-independent group 3 enhancer GRCh37_chr6:133004442-133005641 [Gene]
LOC126859794:MED14-independent group 3 enhancer GRCh37_chr6:133069914-133071113 [Gene]
LOC132089341:Neanderthal introgressed variant-containing enhancer experimental_89871 [Gene]
LOC132089342:Neanderthal introgressed variant-containing enhancer experimental_89876 [Gene]
LOC126859792:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr6:132848222-132849421 [Gene]
LOC123864071:Sharpr-MPRA regulatory region 15532 [Gene]
LINC00326:long intergenic non-protein coding RNA 326 [Gene - HGNC]
RPS12:ribosomal protein S12 [Gene - OMIM - HGNC]
SNORD100:small nucleolar RNA, C/D box 100 [Gene - HGNC]
SNORD101:small nucleolar RNA, C/D box 101 [Gene - HGNC]
SNORA33:small nucleolar RNA, H/ACA box 33 [Gene - HGNC]
SLC18B1:solute carrier family 18 member B1 [Gene - OMIM - HGNC]
STX7:syntaxin 7 [Gene - OMIM - HGNC]
TAAR1:trace amine associated receptor 1 [Gene - OMIM - HGNC]
TAAR2:trace amine associated receptor 2 [Gene - OMIM - HGNC]
TAAR5:trace amine associated receptor 5 [Gene - OMIM - HGNC]
TAAR6:trace amine associated receptor 6 [Gene - OMIM - HGNC]
TAAR8:trace amine associated receptor 8 [Gene - OMIM - HGNC]
TAAR9:trace amine associated receptor 9 [Gene - OMIM - HGNC]
VNN1:vanin 1 [Gene - OMIM - HGNC]
VNN2:vanin 2 [Gene - OMIM - HGNC]
VNN3:vanin 3 [Gene - OMIM - HGNC]

Variant type:

copy number gain

Cytogenetic location:

6q23.2

Genomic location:

Preferred name:

GRCh38/hg38 6q23.2(chr6:132455272-133141153)x3

HGVS:

NC_000006.12:g.(?_132455272)_(133141153_?)dup
NC_000006.10:g.(?_132818104)_(133503985_?)dup
NC_000006.11:g.(?_132776411)_(133462292_?)dup

Links:

dbVar: nssv581239; dbVar: nsv532069

Observations:

Condition(s)

Name:: See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000080746	GeneDx	criteria provided, single submitter (Kaminsky et al. (Genet Med. 2011))	Uncertain significance (Aug 12, 2011)	not provided	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000080746

GeneDx

criteria provided, single submitter

(Kaminsky et al. (Genet Med. 2011))

Uncertain significance
(Aug 12, 2011)

not provided

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	not provided	yes	1	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.

Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, Collinson MN, Beal SJ, Ackley T, Pickering DL, Golden DM, Aston E, Whitby H, et al.

Genet Med. 2011 Sep;13(9):777-84. doi: 10.1097/GIM.0b013e31822c79f9.

PubMed [citation]

PMID:: 21844811
PMCID:: PMC3661946

Details of each submission

From GeneDx, SCV000080746.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	not provided	yes	not provided	not provided	Discovery		1	not provided	not provided	not provided

Last Updated: Oct 14, 2023

ClinVar

Relating variation to medicine